Xiangjun Yang1,2, Khaliun Erdenebat3, Uuganbayar Baatartsogt4, Khishigjargal Ser-Od1, Ambaga Miyegombo6, Bayarmaa Enkhbat3,6,*
1International School of Mongolian Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.
2Department of Cardiology, Affiliated Hospital of Inner Mongolia University for Nationalities, Tongliao 028002, Inner Mongolia, China.
3School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.
4Institute of Traditional Medicine and Technology of Mongolia, Ulaanbaatar 999097-15160, Mongolia.
5New Medicine Medical University, Ulaanbaatar 999097-15160, Mongolia.
6Mongolia-Japan Hospital, Mongolian National University of Medical Sciences, Ulaanbaatar 999097-15160, Mongolia.
*Corresponding author: Bayarmaa Enkhbat
References
[1] World Health Organization. (2021, June 11). "Ischemic heart disease deaths of cardiovascular disease." Retrieved from
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
[2] Health development center. (2022). "Ischemic heart disease deaths of cardiovascular disease." Retrieved from
http://hdc.gov.mn/media/files.
[3] Badalzadeh, R., Yousefi, B., Majidinia, M., Ebrahimi, H. (2014). Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: Activation of nitric oxide system and mitochondrial KATP channel. J Physiol Sci, 64, 393-400. https://doi.org/10.1007/s12576-014-0333-8.
[4] Granier, M., Massin, F., Pasquie, J.-L. (2013). Pro- and Anti-Arrhythmic Effects of Anti- Anti-Inflammatory Drugs. Anti-inflamm Antiallergy Agents Med Chem 12, 83-93. https://doi.org/10.2174/1871523011312010010.
[5] Tse, G., Sun, B., Wong, S.T., Tse, V., Yeo, J.M. (2016). Anti-arrhythmic effects of hypercalcemia in hyperkalemic, langendorff-perfused mouse hearts. Biomed Reports, 5 (3), 301-310.
[6] Najafi, M., Noroozi, E., Javadi, A., Badalzadeh, R. (2018). Anti-arrhythmogenic and anti-inflammatory effects of troxerutin in ischemia/reperfusion injury of diabetic myocardium. Biomed Pharmacother, 102, 385-391. https://doi.org/ 10.1016/j.biopha.2018.03.047.
[7] Williams, E.A., Russo, V., Ceraso, S., Gupta, D., Barrett-Jolley, R. (2020). Anti-arrhythmic properties of non-antiarrhythmic medications. Pharmacol. Res., 156, 104762.
[8] Wu, S.-J., Li, Y.-C., Shi, Z.-W., Lin, Z.-H., Rao, Z.-H., Tai, S.-C., Chu, M.-P., Li, L., Lin, J.-F. (2017). Alteration of cholinergic anti-inflammatory pathway in rat with the ischemic cardiomyopathy-modified electrophysiological function of heart. J Am Heart Assoc., 6 (9). https://doi.org/10.1161/JAHA.117.006510.
[9] Gatzke, N., Güc, N., Hillmeister, P., Dülsner, A., Le Noble, F., Buschmann, E.E., Ingwersen, M., Bramlage, P., Buschmann, I.R. (2018). Cardiovascular drugs attenuated myocardial resistance against ischemia-induced and reperfusion- induced injury in a rat model of repetitive occlusion. Open Hear, 5 (2). https:// doi.org/10.1136/openhrt-2018-000889.
[10] Liu, K., Wang, F., Wang, S., Li, W.-N., Ye, Q. (2019). Mangiferin attenuates myocardial ischemia-reperfusion injury via MAPK/NRf-2/HO-1/NF-jB in vitro and in vivo. Oxid Med Cell Longev., 2019, 1-12.
[11] Yang, H., Jiang, C., Chen, X., He, K., Hu, Y. (2017). Protective effects of sinomenine against LPS-induced inflammation in pig-lets. Microb. Pathog., 110, 573-577. https://doi.org/10.1016/j.micpath.2017.07.044.
[12] 4 principles of medicine. Huh Hot, (1987), pp. 517-520.
[13] Y. Wang, W.B. Lau, E. Gao, et al. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury Am J Physiol Endocrinol Metab, 298 (3) (2010), p. E663.
[14] M. Amani, S. Jeddi, N. Ahmadiasl, N. Usefzade, J. Zaman Effect of HEMADO on Level of CK-MB and LDH enzymes after ischemia/reperfusion injury in isolated rat heart Bioimpacts, 3 (2) (2013), pp. 101-104.
[15] A. Kutsal, G.S. Saydam, D. Yücel, M. Balk Changes in the serum levels of CK-MB, LDH, LDH1, SGOT and myoglobin due to cardiac surgery J Cardiovasc Surg., 32 (4) (1991), pp. 516-522.
[16] A. Gross, J.M. Mcdonnell, S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis.
[17] C. Laulier, B.S. Lopez The secret life of Bcl-2: apoptosis-independent inhibition of DNA repair by Bcl-2 family members Mutat Res Fund Mol Mech Mutagen, 751 (751) (2012), pp. 247-257.
[18] S. Cory, D.C.S. Huang, J.M. Adams. The Bcl-2 family: roles in cell survival and oncogenesis Oncogene, 22 (53) (2003), p. 8590.
[19] P.S. Prince, K. Dhanasekar, S. Rajakumar Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study Cardiovasc Toxicol, 11 (1) (2011), pp. 58-66.
[20] Cao Z, Hu Y, Wu W, et al. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischemia/reperfusion injury. Cardiovasc Res., 2009; 84: 442-451.
[21] Jian Yang, Hong Jiang, Jun Yang, et al. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kB signaling pathway. Mol Cell Biochem., 2009; 330: 39-46.
[22] Han X, Liu JX, Ma MB, et al. Effects of shuangshen tongguan (SSTG) on TNF-alpha, ICAM-1 during myocardial ischemia-reperfusion injury. Zhongguo Zhong Yao Za Zhi, 2004; 29: 1073-1075.